CSL Limited (ASX: CSL)
CSL Limited (ASX:CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL also split its shares 1-for-3. Meaning, the first investors’ true price was closer to just $0.77 each.
Nowadays, CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
Why The CSL (ASX:CSL) Share Price Jumped Almost 7%
The CSL Limited (ASX:CSL) share price rose by almost 7% today after it reported its FY19 result.
ALL ORDINARIES Index (XAO) Rises, CSL (ASX:CSL) Share Price Grows
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.12% at lunch.
ASX 200 (XJO) To Open Higher, 3 ASX Shares To Watch
The ASX 200 (INDEXASX:XJO)(^AXJO) is expected to open higher today, the USA’s S&P 500 Index (.INX) rose by 1.48% on Tuesday.
Is Ansell Limited (ASX:ANN) Another Australian Success Story?
Founded in the 1890s Ansell Limited (ASX: ANN) is one of Australia’s oldest (and most successful) manufacturing companies.